Avantogen Oncology, Inc. acquires and develops novel compounds to treat patients with various types of cancer. The company was formerly known as Innovate Oncology, Inc. and changed its name to Avantogen Oncology, Inc. in June 2006. Avantogen Oncology, Inc. is based in Los Angeles, California.